From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Slides:

Advertisements

Similar presentations

STDs Valerie Robinson D.O.. Prevention Abstinence Risk reduction Vaccines Male or female condoms Cervical diaphragm might protect against cervical GC,

Advertisements

Unmet need for family planning and low rates of dual method protection among men and women attending HIV care and treatment services in Kenya, Namibia.

HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.

Incorporating HIV Prevention into the Medical Care of Persons Living with HIV Ask ∙ Screen ∙ Intervene Developed by: The National Network of STD/HIV Prevention.

ICTC Team Training 1 ICTC: Roles, Referrals and Linkages.

JORDAN E. LAKE, MD, MSC AAHU SEPTEMBER 2014 Prevention for Positives.

Prevention Interventions for Substance Abuse Professionals.

Pharmacist-Managed HIV Pre-Exposure Prophylaxis (PrEP) Clinic: Preliminary Outcomes From an Urban Community Health Clinic Mark T. Sawkin, PharmD, AAHIVP.

Information about HIV Prevention Options

Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.

Upfront Combination Therapy vs Step-Up Approach for PAH:

Provider Initiated HIV Counseling and Testing

The Patient Experience With Systemic Lupus Erythematosus

Provider Initiated HIV Counseling and Testing

MTN-025 (HOPE Study) Community Education Presentation

HIV-Associated Weight Loss and Wasting

PrEP: A Case-by-Case Approach

HIV and the ART of Prevention

A Review of the Critical Role of Imaging in Primary Liver Malignancy

Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.

Managing Women Living With HIV Infection

Starting Strong: Initial Evaluation of the Patient With HCV

Management of Mild to Moderate Asthma

Medical Factors Affecting Older Driver Safety

Does One Size Fit All in Obesity Management?

PrEP Effectiveness. Preexposure Prophylaxis Translating the Clinical Trials Into Clinical Practice.

Modern Strategies for Basal Insulin Use in T2D

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

Patient-Centered Care in Cystic Fibrosis

How Early Should Basal Insulin Be Used in T2D Management?

Is Your Patient Engaged in Care

PrEP in Women: Unique Considerations and Strategies

Chronic Idiopathic Urticaria

Blood pressure control: dependence on adherence

Screening and Diagnosing Postpartum Depression

Follow-Up of the Patient After PE

Evaluation of the Patient With HCV Infection

Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.

Statins, HIV, and CVD.

Agenda. Agenda HIV in the United States HIV in the United States (cont)

Personalizing Statin Therapy in Patients With HIV

Overview. 5 Things You Need to Know About Statin Selection in Patients With HIV Infection.

Initiating Pre-exposure Prophylaxis The PrEP Checklist

A Case-based Approach to RSV Disease

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

Personalized Therapy in Relapsed or Refractory CLL

Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.

Statins, HIV, and CVD.

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

PrEP Ongoing Care.

Revisiting the Pharmacoeconomics of HF

Parkinson Disease Psychosis

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

Management of Systemic Lupus Erythematosus

Optimizing Joint Health in Hemophilia

Challenges in LA SCCHN.

Improving Adherence to Antiplatelet Therapy After an ACS Event

Prism Health North Texas Programs and Services

Merging the Art and Science of Managing nOH in Clinical Practice

The Building Blocks of Homocystinuria and Homocysteinemia Management

Ask the Psoriasis Expert

Shared Decision Making in MS

Bob Holtkamp, Director of Prevention & Outreach

Motor Fluctuations in PD

Best Practices in Building HIV Care Networks

Presentation transcript:

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

What Is PrEP?

PrEP Is Recommended for Persons at Substantial Risk of Acquiring HIV Infection

PrEP is Effective: Adherence Is Critical

Case: Bob, a 38-Year-Old Man

Clinical Eligibility for PrEP

Bob Is Eligible for PrEP, but …

How Would You Counsel Bob Before Initiating PrEP?

Other Factors to Assess Before Initiating PrEP

Initiating PrEP in Bob

Medication Adherence Counseling

Common Questions Patients Ask About PrEP

Common Questions Patients Ask About PrEP (cont)

PrEP + Condoms = Protection Against HIV Infection and Other STIs

Follow-up After Initiation of PrEP

Behavioral Risk Reduction Counseling

Concluding Remarks

Abbreviations